{
  "actions": [
    {
      "acted_at": "2003-06-19",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2003-06-19",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-06-19",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2003-06-23",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Trade.",
      "type": "referral"
    },
    {
      "acted_at": "2003-06-24",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hconres225-108",
  "bill_type": "hconres",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Trade",
      "subcommittee_id": "04"
    }
  ],
  "congress": "108",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2003-06-19",
  "number": "225",
  "official_title": "Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": null,
  "sponsor": {
    "bioguide_id": "M001137",
    "district": "6",
    "name": "Meeks, Gregory W.",
    "state": "NY",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2003-06-19",
  "subjects": [
    "Access to health care",
    "Canada",
    "Commerce",
    "Congress",
    "Consumer education",
    "Consumer protection",
    "Crime and Law Enforcement",
    "Crime prevention",
    "Drug approvals",
    "Drug industry",
    "Drugs",
    "Foreign trade and international finance",
    "Health",
    "Health care industry",
    "Health education",
    "Imports",
    "Legislation",
    "Medicare",
    "Prescription pricing",
    "Price discrimination",
    "Smuggling",
    "Social Welfare"
  ],
  "subjects_top_term": "Foreign trade and international finance",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2003-06-19",
    "date": "2006-11-28T17:35:40Z",
    "text": "Expresses the sense of Congress that: (1) the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers; (2) the President should take action to prevent the illegal importation of prescription drugs from Canada or any other foreign country; (3) the United States Trade Representative should take action to correct the inequities and discrimination caused by Canada's Patented Medicine Pricing Review Board; (4) the pharmaceutical industry and the health care community should work with United States consumers to lower the price of prescription drugs and should mount a nationwide educational awareness program regarding the dangers of imported drugs and medicines; and (5) Congress should enact a Medicare drug benefit as the best and safest way for United States patients to obtain their prescription drugs."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-01-15T16:03:43Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/hconres/BILLSTATUS-108hconres225.xml"
}